Status:
COMPLETED
Effect Of Intravenous IntralipidTherapyon Pregnancy Outcome in Women With History of Recurrent Implantation Failure Undergoing Intracytoplasmic Sperm Injection-Embryo Transfer Cycle: A Randomized Controlled Trial
Lead Sponsor:
King Fahad Medical City
Conditions:
Infertility Due to Nonimplantation
Eligibility:
FEMALE
21-42 years
Phase:
PHASE2
Brief Summary
To evaluate the effect ofempiricintralipidinfusion therapy on pregnancy outcomes in patient withunexplained recurrentimplantation failure (RIF) undergoIntracytoplasmic sperm injection (ICSI).
Detailed Description
the aim to evaluate the effect ofempiricintralipidinfusion therapy on pregnancy outcomes in patient withunexplained recurrentimplantation failure (RIF) undergoIntracytoplasmic sperm injection (ICSI). ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- age \< 42 years
- BMI \< 30 kg/m2
- history of 3 or more recurrent implantation failure undergoing Intracytoplasmic Sperm Injection (ICSI ) cycle.
- exclusion criteria
- women with medical contraindications of intralipidinfusion.
- uterine fibroid.
- endometrial polyp.
- endometriosis,hydrosalpinx.
- intrauterine adhesion and uterine anomalies.
- Women with positive thrombophilia screen.
- diminished ovarian reserve.
- severe male factor infertility .
- chronic medical illnesses which may contribute in impaired chance of pregnancy .
Exclusion
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2017
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT03374163
Start Date
January 1 2015
End Date
June 30 2017
Last Update
December 15 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.